GSK Share PerformanceMore
|52 week high||1,745.5 11/10/16|
|52 week low||1,446.5 06/12/16|
|52 week change||229.0 (15.45%)|
|4 week volume||165,360,195 31/05/17|
Latest News« previous» nextMore
22/06/2017 - 16:59 StockMarketWire
Investor sentiment remained subdued as insurance and utility stocks weighed on the FTSE. Direct Line (DLG) fell 1.9% to 3...
21/06/2017 - 14:35 RNS
RNS Number: 7867I GlaxoSmithKline PLC 21 June 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mrs V A Whyte b) Position/status Company Secretary c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, auct...
21/06/2017 - 14:24 StockMarketWire
GSK has confirmed that it will be presenting new results from a clinical study showing that its candidate vaccine for the p...
21/06/2017 - 14:05 RNS
RNS Number: 7784I GlaxoSmithKline PLC 21 June 2017 Issued: 21 June 2017, London UK - LSE GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting Study conducted in individuals who had previously received current standard of care GSK [LSE/NYSE: GSK] today will be presenting new...
20/06/2017 - 08:39 StockMarketWire
GlaxoSmithKline has confirmed that Luke Miels would start his appointment as president, global pharmaceuticals, on 4 Se...
19/06/2017 - 16:29 RNS
RNS Number: 5167I GlaxoSmithKline PLC 19 June 2017 Issued: Monday 19 June 2017, London UK - LSE GSK confirms start date for Luke Miels GSK has reached an agreement with AstraZeneca that Luke Miels will commence his appointment as President, Global Pharmaceuticals, GSK on 4 September 2017 . GSK enquiries: UK Media enquiries: Simon Steel +44 (0) 20...
16/06/2017 - 14:31 Interactive Investor
The FTSE reshuffle takes effect Monday, while investors get an update from a retailer just days after grim retail sales data...
16/06/2017 - 09:00 StockMarketWire
Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price...
|Dividend yield||4.676 %|
Latest discussion posts More
“Games I have never been a Woody watcher, childish really to gloat at seeing the so called kings falling, but entertaining (and I appreciate the calculations) to watch the ...”▼
“Summary Day 19 - GSK retaining an above 11% lead at 11.09% Today GSK edges up 0.15% in a strong up market and Lloyds gets another battering down 0.27% -- swing to GSK is ...”▼
“And a tired old bunch of drugs they were too. Witty got a very good price for them if my memory serves me correctly. Would not expect Woody to hand out plaudits as his ...”▼
Codes & Symbols
|Symbols||GSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK|